Severe Fatal Systemic Embolism Due to Non-Bacterial Thrombotic Endocarditis as the Initial Manifestation of Gastric Adenocarcinoma: Case Report

1. el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis and treatment. Oncologist. 2007;12:518-23.10.1634/theoncologist.12-5-518Search in Google Scholar

2. Chen H, Fritz T, Banga P, Wohns D, Cohle S, Banga S. The search for cryptogenic stroke, a case of marantic endocarditis. Int J Cardiovasc Cerebrovasc Dis. 2014;2:39-43.10.13189/ijccd.2014.020401Search in Google Scholar

3. Borowski A, Ghodsizad A, Cohnen M, Gams E. Recurrent embolism in the course of marantic endocarditis. Ann Thorac Surg. 2005;79:2145-7.10.1016/j.athoracsur.2003.12.024Open DOISearch in Google Scholar

4. Llenas-Garcia J, Guerra-Vales JM, Montes-Moreno S, López-Rios F, Castelbón-Fernández FJ, Chimeno-Garcia J. Nonbacterial thrombotic endocarditis: clinicopathologic study of a necropsy series. Rev Esp Cardiol. 2007;60:493-500.10.1016/S1885-5857(07)60190-XSearch in Google Scholar

5. Gonzales Quintela A, Candela MJ, Vidal C, Roman J, Aramburo P. Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol. 1991;46:1-9.Search in Google Scholar

6. Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003;21:4194-9.10.1200/JCO.2003.05.16514615447Open DOISearch in Google Scholar

7. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992;11:249-66.10.1007/BF013071811423817Open DOISearch in Google Scholar

8. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4:465-73.10.1038/sj.neo.7900263155033912407439Search in Google Scholar

9. Chaturvedi P, Singh AP, Batra SK. Structure, evolution and biology of MUC4 mucin. FASEB J. 2008;22:966-81.10.1096/fj.07-9673rev283549218024835Open DOISearch in Google Scholar

10. Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110:1723-9.10.1182/blood-2006-10-053736197637717496204Search in Google Scholar

11. Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis. 2008;17:169-74.10.1016/j.jstrokecerebrovasdis.2008.01.00718589335Open DOISearch in Google Scholar

12. Scalia GM, Tandon AK, Robertson JA. Stroke, aortic vegetations and disseminated adenocarcinoma- case of marantic endocarditis. Heart Lung Circ. 2012;21:234-6.10.1016/j.hlc.2011.08.00321885337Open DOISearch in Google Scholar

13. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62:2025-30.10.1212/01.WNL.0000129912.56486.2BSearch in Google Scholar

14. Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33:1267-73.10.1161/01.STR.0000015029.91577.36Search in Google Scholar

15. Hong CT, Tsai LK, Jeng JS. Patterns of acute cerebral infarcts in patients with active malignancy using diffusion-weighted imaging. Cerebrovasc Dis. 2009;28:411-6.10.1159/00023562919696480Open DOISearch in Google Scholar

16. Sturgeon CM, Duffy MJ, Hofmann BR et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical and gastric cancers. Clin Chem. 2010;56:e1-48.10.1373/clinchem.2009.13312420207771Search in Google Scholar

17. Uemura J, Kimura K, Sibazaki K, Inoue T, Iguchi Y, Yamashita S. Acute stroke patients have occult malignancy more often than expected. Eur Neurol. 2010;64:140-4.10.1159/00031676420668384Open DOISearch in Google Scholar

18. Bajkó Z, Bălaşa R, Moţăţăianu A et al. Malignant Middle Cerebral Artery Infarction Secondary to Traumatic Bilateral Internal Carotid Artery Dissection. A Case Report. J Crit Care Med. 2016;2:135-41.10.1515/jccm-2016-0021595324929967852Search in Google Scholar

19. Mohr JP, Thompson JL, Lazar RM et al. A comparison of warfarin and aspirin for prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-51.10.1056/NEJMoa01125811794192Search in Google Scholar

20. Lee AY, Levine MN, Baker RI, Bowden C et al. Low-molecularweight heparin versus coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.N Engl J Med. 2003;349:146-53.10.1056/NEJMoa02531312853587Search in Google Scholar

21. Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis 9thed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e576S-e600s.10.1378/chest.11-2305327805722315272Search in Google Scholar